Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03452774
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:01.078916+00:00
Published At
2025-10-28T00:00:00+00:00
Record Updated At
2025-10-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Cancer, Metastatic", "Cancer", "Cancer of Pancreas", "Cancer of Liver", "Cancer of Stomach", "Cancer Liver", "Cancer of Rectum", "Cancer of Kidney", "Cancer of Esophagus", "Cancer of Cervix", "Cancer of Colon", "Cancer of Larynx", "Cancer, Lung", "Cancer, Breast", "Cancer, Advanced", "Cancer Prostate", "Cancer of Neck", "Cancer of Skin", "Neuroendocrine Tumors", "Carcinoma", "Mismatch Repair Deficiency", "BRCA Gene Rearrangement", "Non Hodgkin Lymphoma", "Leukemia", "Non Small Cell Lung Cancer", "Cholangiocarcinoma", "Glioblastoma", "Central Nervous System Tumor", "Melanoma", "Urothelial Carcinoma", "Bladder Cancer", "Ovarian Cancer", "Endometrial Cancer", "Testicular Cancer", "Breast Cancer", "COVID", "Myelofibrosis", "Myeloproliferative Neoplasm", "Myeloproliferative Disorders", "Follicular Lymphoma", "Mantle Cell Lymphoma", "Marginal Zone Lymphoma", "Myelodysplastic Syndromes"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-10-28"
protocolSection.identificationModule.nctId
"NCT03452774"
protocolSection.identificationModule.officialTitle
"SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Cancer, Metastatic (protocolSection.conditionsModule.conditions)
  • Cancer (protocolSection.conditionsModule.conditions)
  • Cancer of Pancreas (protocolSection.conditionsModule.conditions)
  • Cancer of Liver (protocolSection.conditionsModule.conditions)
  • Cancer of Stomach (protocolSection.conditionsModule.conditions)
  • Cancer Liver (protocolSection.conditionsModule.conditions)
  • Cancer of Rectum (protocolSection.conditionsModule.conditions)
  • Cancer of Kidney (protocolSection.conditionsModule.conditions)
  • Cancer of Esophagus (protocolSection.conditionsModule.conditions)
  • Cancer of Cervix (protocolSection.conditionsModule.conditions)
  • Cancer of Colon (protocolSection.conditionsModule.conditions)
  • Cancer of Larynx (protocolSection.conditionsModule.conditions)
  • Cancer, Lung (protocolSection.conditionsModule.conditions)
  • Cancer, Breast (protocolSection.conditionsModule.conditions)
  • Cancer, Advanced (protocolSection.conditionsModule.conditions)
  • Cancer Prostate (protocolSection.conditionsModule.conditions)
  • Cancer of Neck (protocolSection.conditionsModule.conditions)
  • Cancer of Skin (protocolSection.conditionsModule.conditions)
  • Neuroendocrine Tumors (protocolSection.conditionsModule.conditions)
  • Carcinoma (protocolSection.conditionsModule.conditions)
  • Mismatch Repair Deficiency (protocolSection.conditionsModule.conditions)
  • BRCA Gene Rearrangement (protocolSection.conditionsModule.conditions)
  • Non Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Leukemia (protocolSection.conditionsModule.conditions)
  • Non Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Glioblastoma (protocolSection.conditionsModule.conditions)
  • Central Nervous System Tumor (protocolSection.conditionsModule.conditions)
  • Melanoma (protocolSection.conditionsModule.conditions)
  • Urothelial Carcinoma (protocolSection.conditionsModule.conditions)
  • Bladder Cancer (protocolSection.conditionsModule.conditions)
  • Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Endometrial Cancer (protocolSection.conditionsModule.conditions)
  • Testicular Cancer (protocolSection.conditionsModule.conditions)
  • Breast Cancer (protocolSection.conditionsModule.conditions)
  • COVID (protocolSection.conditionsModule.conditions)
  • Myelofibrosis (protocolSection.conditionsModule.conditions)
  • Myeloproliferative Neoplasm (protocolSection.conditionsModule.conditions)
  • Myeloproliferative Disorders (protocolSection.conditionsModule.conditions)
  • Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.